← Back to Search

PrEP Information Strategies for HIV Prevention

N/A
Recruiting
Led By Christofer J Skurka, PhD
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up will be measured immediately after completing the browsing task
Awards & highlights

Study Summary

This trial tests different messaging strategies that could increase the awareness of PrEP (HIV prevention) amongst young men who are sexually active. Participants will browse a mock Google results page with various PrEP information and their behavior will be logged.

Who is the study for?
This trial is for HIV-negative, gay or bisexual cisgender males aged 18-34 who've had anal sex in the past 6 months. They must either have an HIV-positive partner, inconsistent condom use, or a recent STI diagnosis. Participants need internet access for Study 1.Check my eligibility
What is being tested?
The study tests how young men respond to online information about oral and injectable PrEP (a medication regimen that helps prevent HIV). It tracks which messages are most engaging by monitoring browsing and visual behavior with eye-trackers in Study 2.See study design
What are the potential side effects?
Since this trial involves gathering information rather than taking medications, there are no direct side effects from interventions. However, participants may experience discomfort due to the use of eye-tracking equipment in Study 2.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~recorded while participants complete the google results browsing task (3 minutes max)
This trial's timeline: 3 weeks for screening, Varies for treatment, and recorded while participants complete the google results browsing task (3 minutes max) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Browsing behavior - First click
Browsing behavior - Total page duration
Visual behavior - Total fixation duration (Study 2 only)
Secondary outcome measures
Change in intention to adopt PrEP
Open-ended responses

Trial Design

2Treatment groups
Experimental Treatment
Group I: Oral PrEP information (Study 1 only)Experimental Treatment1 Intervention
A mock Google search results page with five search results that reflect five messaging strategies about oral PrEP (response efficacy, social norms, exemplar, celebrity, and basic information), displayed in random order.
Group II: Injectable PrEP informationExperimental Treatment1 Intervention
A mock Google search results page with five search results that reflect five messaging strategies about injectable PrEP (response efficacy, social norms, exemplar, celebrity, and basic information), displayed in random order.

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor
355 Previous Clinical Trials
125,082 Total Patients Enrolled
Christofer J Skurka, PhDPrincipal InvestigatorPenn State University

Media Library

Injectable PrEP information Clinical Trial Eligibility Overview. Trial Name: NCT05728034 — N/A
Pre-Exposure Prophylaxis Research Study Groups: Injectable PrEP information, Oral PrEP information (Study 1 only)
Pre-Exposure Prophylaxis Clinical Trial 2023: Injectable PrEP information Highlights & Side Effects. Trial Name: NCT05728034 — N/A
Injectable PrEP information 2023 Treatment Timeline for Medical Study. Trial Name: NCT05728034 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I qualify for participation in this medical research?

"This medical experiment seeks to enrol 675 individuals aged 18-34 who identify as gay or bisexual and have pre-exposure prophylaxis. Moreover, the participants must meet certain criteria: HIV negative status; anal intercourse in the past 6 months; a sexual partner with HIV, inconsistent condom use, or an STD diagnosis within half a year (Study 1 only); possess an Internet-connectable device (for Study 1 only) and be cisgender male."

Answered by AI

Is the enrollment criteria for this experiment limited to adults?

"This trial is recruiting individuals aged 18-34 years old."

Answered by AI

Are there any open participant slots available in this clinical trial?

"Clinicaltrials.gov reveals that this medical experiment, first posted on July 1st 2023 and last updated on February 13th 2023 is not currently seeking applicants. However, there are presently 7 other trials recruiting patients."

Answered by AI
~262 spots leftby Dec 2024